ASTEX PHARMACEUTICALS, INC Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
ASTEX PHARMACEUTICALS, INC reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of $903.00 thousand for the 3-month period ending 2011-06-30, per its 10-Q filed 2011-08-09.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2011-08-09
- ASTEX PHARMACEUTICALS, INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2011-06-30 was $903.00K, a 6.04% decline year-over-year.
- ASTEX PHARMACEUTICALS, INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2010-06-30 was $961.00K.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month |
|---|---|---|
| 2011-06-30 | $903.00K 10-Q · filed 2011-08-09 | $6.39M 10-Q · filed 2011-08-09 |
| 2010-06-30 | $961.00K 10-Q · filed 2011-08-09 | $5.63M 10-Q · filed 2011-08-09 |